نتایج جستجو برای: aprotinin

تعداد نتایج: 1927  

Journal: :Physiological research 2013
P Maruna A A Klein J Kunstýř K M Plocová F Mlejnský J Lindner

Aprotinin, a nonspecific serine protease inhibitor, has been primarily used as a haemostatic drug in cardiac surgery with cardio-pulmonary bypass (CPB). This study investigated the effect of aprotinin on the post-operative levels of procalcitonin (PCT) and a set of cytokines in patients undergoing pulmonary artery endarterectomy (PEA). We analyzed 60 patients with chronic thromboembolic pulmona...

2011
F Fleischmann C Matuschek K Orth PA Gerber R Mota WT Knoefel M Peiper M Schick M van Griensven E Bdlke W Fleischmann

BACKGROUND Classic wound drainage is still common in hip replacement but its benefit is doubtful. The role of systemic administration of proteinase inhibitors like aprotinin to avoid perioperative blood loss is still unclear. PATIENTS AND METHODS In a prospective randomized trial, the perioperative blood loss in alloplastic hip replacement under the influence of proteinase inhibitor (aprotini...

Journal: :The journal of extra-corporeal technology 2002
Jun-Li Liu Alfred H Stammers Hong Zheng Nancy J Mills Jeffery D Nichols Scott A Kmiecik Ryan J Kohtz Craig M Petterson

Cardiotomy suction enhances inflammation and fibrinolysis during cardiopulmonary bypass (CPB). Aprotinin has been shown to reduce the generalized inflammatory insults associated with CPB. The purpose of this study was to evaluate the effect of Aprotinin administration through cardiotomy suction on the inflammatory and fibrinolytic responses during CPB. A pig model of CPB was utilized including ...

Journal: :European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1997
S J Rooney D Pagano G Bognolo C Wong R S Bonser

OBJECTIVE The use of aprotinin in cardiac surgery to improve haemostasis and reduce blood loss particularly in patient groups at increased risk of bleeding is well established. Previous retrospective studies in profound hypothermic surgery have highlighted concerns that in this circumstances aprotinin may paradoxically cause increased bleeding and intravascular thrombosis. We therefore adopted ...

2008
H. TEIMOURI

Background: Aprotinin has been used increasingly to reduce postoperative blood loss in open-heart operations; due to the potentialities for complications and high cost, it would seem reasonable to use aprotinin more selectively in small doses in the prime solution of the pump. Methods: We prospectively studied the effect of preoperative low dose aprotinin [2 million units (230mg)] on blood loss...

Journal: :BMC Cardiovascular Disorders 2005
Paul A Carless Annette J Moxey Barrie J Stokes David A Henry

BACKGROUND Aprotinin has been shown to be effective in reducing peri-operative blood loss and the need for re-operation due to continued bleeding in cardiac surgery. The lysine analogues tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) are cheaper, but it is not known if they are as effective as aprotinin. METHODS Studies were identified by searching electronic databases and bibliog...

2016
Charlotte Denholt Nic Gillings

Technetium-99m aprotinin was prepared from an optimised radiolabelling kit formulation containing aprotinin, alkaline buffer and stannous chloride (reducing agent) and radiolabelled using (99m) Tc-pertechnetate. The labelling was achieved within 25 min, with radiochemical purities of >98%.

Journal: :Agents and actions. Supplements 1992
M Siebeck M Spannagl H Hoffmann E Fink

Endotoxin shock and contact system activation were used to study effects of hirudin, antithrombin III, eglin C, aprotinin, and [Arg15]-aprotinin in anesthetized pigs. Alterations in the systemic and pulmonary circulation were in part prevented by administration of the inhibitors.

Journal: :The Journal of pharmacology and experimental therapeutics 2008
Michel Demeule Anthony Régina Christian Ché Julie Poirier Tran Nguyen Reinhard Gabathuler Jean-Paul Castaigne Richard Béliveau

By controlling access to the brain, the blood-brain barrier (BBB) restricts the entry of proteins and potential drugs to cerebral tissues. We demonstrate here the transcytosis ability of aprotinin and peptides derived from Kunitz domains using an in vitro model of the BBB and in situ brain perfusion. Aprotinin transcytosis across bovine brain capillary endothelial cell (BBCEC) monolayers is at ...

Journal: :Investigative ophthalmology & visual science 2008
Dimitra Skondra Kousuke Noda Lama Almulki Faryan Tayyari Sonja Frimmel Toru Nakazawa Ivana K Kim Souska Zandi Kennard L Thomas Joan W Miller Evangelos S Gragoudas Ali Hafezi-Moghadam

PURPOSE Azurocidin, released by neutrophils during leukocyte-endothelial interaction, is a main cause of neutrophil-evoked vascular leakage. Its role in the retina, however, is unknown. METHODS Brown Norway rats received intravitreal injections of azurocidin and vehicle control. Blood-retinal barrier (BRB) breakdown was quantified using the Evans blue (EB) dye technique 1, 3, and 24 hours aft...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید